MedPath

Eplerenone

These highlights do not include all the information needed to use Eplerenone Tablets safely and effectively. See full prescribing information for Eplerenone Tablets.Initial U.S. Approval: 2002

Approved
Approval ID

e8323922-191d-4bfc-8871-fbe15a8a7b58

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 7, 2012

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Eplerenone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6065
Application NumberANDA078510
Product Classification
M
Marketing Category
C73584
G
Generic Name
Eplerenone
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 7, 2012
FDA Product Classification

INGREDIENTS (9)

EPLERENONEActive
Quantity: 25 mg in 1 1
Code: 6995V82D0B
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Eplerenone - FDA Drug Approval Details